The paths of these two stars have intersected on several occasions due to their association with the luxury brand Bulgari
entertainment4 hours ago
A potential new malaria vaccine has proved highly effective in a trial in babies in Africa, pointing to it one day possibly helping reduce the death toll from the mosquito-born disease that kills up to half a million young children a year.
The candidate vaccine, developed by scientists at Britain's University of Oxford and called R21/Matrix-M, showed up to 77 per cent efficacy in the year-long trial of 450 children in Burkina Faso, researchers leading the trial said in a statement.
The scientists, led by Adrian Hill, director of Oxford's Jenner Institute and also one of the lead researchers behind the Oxford-AstraZeneca COVID-19 vaccine, said they now plan to conduct final stage trials in some 4,800 children aged between 5 months and 3 years in four African Countries.
Hill said he had "high expectations for the potential of this vaccine" which he said would be the first against malaria to reach a World Health Organization (WHO) goal of a malaria shot with at least 75 per cent efficacy.
Scientists around the world have been working for decades to develop a vaccine to prevent malaria - a complex infection caused by a parasite carried in the saliva of mosquitoes.
Malaria infects millions of people every year and kills more than 400,000 - most of them babies and young children in the poorest parts of Africa.
The world's first and only licensed malaria vaccine, Mosquirix, was developed by GlaxoSmithKline over many years of clinical trial across several African countries, but is only partially effective at around 30%.
In the R21/Matrix-M trial in Burkina Faso, the 450 young children were divided into three groups. Two groups got three doses of the experimental vaccine along with either a low or a high dose of an adjuvant - an ingredient designed to super-charge the body's response to a vaccine - while the third group was given a control vaccine.
Results, which researchers said would soon be published in The Lancet medical journal, showed efficacy of 77 per cent in the high-dose adjuvant group and 74 per cent among those who got the vaccine with a low-dose of adjuvant.
The paths of these two stars have intersected on several occasions due to their association with the luxury brand Bulgari
entertainment4 hours ago
The students' demands range from a ceasefire in Israel's war with Hamas to calls for universities to stop investing in Israeli enterprises
world4 hours ago
Despite Kohli's flowing form ahead of the T20 World Cup in June, pundits have raised concerns over his strike-rate
cricket4 hours ago
Saudi Arabia has begun to explore extracting lithium from sea water
business5 hours ago
Speaking after meeting Lebanese leaders, French foreign minister says there had been "a lot of progress" over the French proposals
mena5 hours ago
The three-shot winner from Japan says he is aiming to become a member of the PGA Tour in the future
sports5 hours ago
Big-hitting Nienaber falters at the finish to settle for secondwhile former Abu Dhabi resident David Horsey takes the third spot at Saadiyat Beach Golf Club
sports5 hours ago
The UAE is India's second-largest export destination after the US
economy5 hours ago